Arzeda

Seattle, United States

Arzeda is a protein design company that creates and manufactures proteins and enzymes for pharmaceuticals and industrial chemicals.

$38.0M raised

Sep 2024

Series C

Top Investors

National Science FoundationSofinnova PartnersCasdin CapitalCirculate CapitalLewis & Clark AgriFood

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Arzeda raised?

Arzeda has raised $38.0M in total funding. The most recent round was Series C. The last funding was announced in September 2024.

Who are Arzeda's investors?

Arzeda's investors include National Science Foundation, Sofinnova Partners, Casdin Capital, Circulate Capital, Lewis & Clark AgriFood.

Where is Arzeda headquartered?

Arzeda is headquartered in Seattle, United States.

What does Arzeda do?

Arzeda is a protein design company that creates and manufactures proteins and enzymes for pharmaceuticals and industrial chemicals.

What stage is Arzeda at?

Arzeda is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 17, 2024.

MLA

"Arzeda — Funding & Investors." VCBacked, September 17, 2024, https://www.vcbacked.co/company/arzeda. Accessed June 9, 2026.

APA

VCBacked. (2024). Arzeda — Funding & Investors. Retrieved June 9, 2026, from https://www.vcbacked.co/company/arzeda

Wikipedia (cite web)

{{cite web |title=Arzeda — Funding & Investors |url=https://www.vcbacked.co/company/arzeda |website=VCBacked |access-date=June 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 17, 2024.